Oncternal Therapeutics Inc. buy HC Wainwright
Start price
27.12.23
/
50%
€0.54
Target price
27.12.24
€1.81
Performance (%)
-41.48%
Price
05.01.24
€0.32
Summary
This prediction is currently active. Massive losses of -41.48% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 27.12.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Oncternal Therapeutics Inc. | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by HC_Wainwright for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Ratings data for ONCT provided by MarketBeat
Stopped prediction by HC_Wainwright for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
15.04.24
15.04.24
€26.28
15.04.25
15.04.25
-
05.01.24
05.01.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
29.01.24
29.01.24
€27.72
29.01.25
29.01.25
-
05.01.24
05.01.24